TMCnet - World's Largest Communications and Technology Community



Supernus at Citibank and RBC Global Healthcare Conferences in February
[February 07, 2014]

Supernus at Citibank and RBC Global Healthcare Conferences in February

ROCKVILLE, Md. --(Business Wire)--

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company, today announced that the Company's management will be hosting investor meetings during Citi's 2014 Global Healthcare Conference.

Date: Tuesday, February 25
Place: The Hilton New York Hotel

Investors interested in arranging a meeting during this conference should contact their Citi representative.

Supernus also announced that management will providea business update on the Company at the 2014 RBC Capital Markets Global Healthcare Conference.

Date: Wednesday, February 26
Presentation Time: 9:00am ET
Place: The New York Palace, New York, NY

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The Company has two marketed products for epilepsy, Oxtellar XR® (extended-release oxcarbazepine) and Trokendi XR™ (extended-release topiramate). The Company is also developing several product candidates in psychiatry to address large market opportunities in ADHD, including ADHD patients with impulsive aggression. These product candidates include SPN-810 for impulsive aggression in ADHD and SPN-812 for ADHD.

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy